Seminars in Nuclear Medicine

Papers
(The median citation count of Seminars in Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation78
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives69
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?68
Application of Deep Learning in Breast Cancer Imaging66
Imaging of Head and Neck Cancer With CT, MRI, and US59
Imaging of COVID-19: CT, MRI, and PET51
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders50
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions44
Ethical and Legal Challenges of Artificial Intelligence in Nuclear Medicine43
Intelligent Imaging in Nuclear Medicine: the Principles of Artificial Intelligence, Machine Learning and Deep Learning42
Recent Developments in SPECT/CT41
[18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications37
PET/MR in Head and Neck Cancer – An Update34
Clinical Management of COVID-19 Patients – An Update34
Advances in Brain Amyloid Imaging33
Radiomics in PET/CT: Current Status and Future AI-Based Evolutions33
A role of FDG-PET/CT for response evaluation in metastatic breast cancer?31
Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images31
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer30
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update29
Sentinel Lymph Node Methods in Breast Cancer28
FDG-PET/CT of COVID-19 and Other Lung Infections28
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers27
Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies27
16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer26
Imaging for Response Assessment in Cancer Clinical Trials26
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls26
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review26
Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer25
Hyperpolarized MRI – An Update and Future Perspectives24
PET Agents in Dementia: An Overview24
PET/CT in Bladder Cancer: An Update23
Social Asymmetry, Artificial Intelligence and the Medical Imaging Landscape23
Radiation Dosimetry in 177Lu-PSMA-617 Therapy23
Clinical Use of PET/MR in Oncology: An Update23
Digital PET vs Analog PET: Clinical Implications?22
PET/CT in Non-Hodgkin Lymphoma: An Update22
Total-body PET/CT – First Clinical Experiences and Future Perspectives22
Imaging for Target Delineation in Head and Neck Cancer Radiotherapy21
Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine20
PET/CT Variants and Pitfalls in Gynecological Cancers20
How to Design AI-Driven Clinical Trials in Nuclear Medicine20
PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer19
Measurement of Glomerular Filtration Rate18
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget18
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls18
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma17
Advancement in Production of Radiotracers17
FDG PET/CT for Evaluation of Immunotherapy Response in Lung Cancer Patients17
Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT17
PET/CT in Surgical Planning for Head and Neck Cancer17
Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma16
Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography16
Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use16
The Impact of Radiopharmaceutical Therapy on Renal Function16
A Role for FDG PET Radiomics in Personalized Medicine?15
PET/CT in Hodgkin Lymphoma: An Update15
Advances in PET/CT Technology: An Update15
Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections14
Hybrid Imaging of Vascular Cognitive Impairment14
Artificial Intelligence for Response Evaluation With PET/CT14
Molecular Imaging of Fever of Unknown Origin: An Update14
A Role of PET/MR in Breast Cancer?13
The Value of the Standardized Uptake Value (SUV) and Metabolic Tumor Volume (MTV) in Lung Cancer13
Multimodality Imaging and Artificial Intelligence for Tumor Characterization: Current Status and Future Perspective13
PET/CT Variants and Pitfalls in Breast Cancers13
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy13
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer13
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies13
PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview12
Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine12
Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and M12
18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD)12
PET/MR Technology: Advancement and Challenges12
SPECT and PET Radiotracers in Renal Imaging12
Role of Non-FDG-PET/CT in Head and Neck Cancer12
Mediastinal Masses: 18F-FDG-PET/CT Features Based on the International Thymic Malignancy Interest Group Classification12
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy12
PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker?11
FDG PET/CT Imaging of Sarcoidosis11
Pitfalls on PET/MRI11
Variants and Pitfalls of PET/CT in Neuroendocrine Tumors11
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment11
Molecular Imaging of Tuberculosis11
Preclinical Research Highlighting Contemporary Targeting Mechanisms of Radiolabelled Compounds for PET Based Infection Imaging11
Applications of Artificial Intelligence in PSMA PET/CT for Prostate Cancer Imaging11
PET/CT Normal Variants and Pitfalls in Pediatric Disorders10
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update10
Molecular imaging Theranostics of Neuroendocrine Tumors10
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence10
Role of FDG PET/CT in Management of Patients with Prostate Cancer10
Nuclear Medicine Departments in the Era of COVID-199
Nuclear medicine imaging methods of radiation-induced cardiotoxicity9
Imaging of Invasive Fungal Infections- The Role of PET/CT9
Parathyroid Imaging9
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies9
Recent Advancements in CT and MR Imaging of Prostate Cancer9
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer9
Update on Imaging of Inflammatory Arthritis and Related Disorders9
Added Value of Respiratory Gating in Positron Emission Tomography for the Clinical Management of Lung Cancer Patients9
Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma8
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma8
Interim FDG-PET/CT for Response Assessment of Lymphoma8
PET/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer8
Vascular Graft Infection Imaging8
PET Assessment of Cardiac Allograft Vasculopathy8
Autoimmune Thyroid Diseases8
“PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”8
Molecular Imaging of Periprosthetic Joint Infections8
Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer Therapy8
Advances in Preclinical PET8
Pitfalls of Radionuclide Renal Imaging in Pediatrics8
Gallium-68 Labelled Radiopharmaceuticals for Imaging Inflammatory Disorders7
Pitfalls on PET/CT Due to Artifacts and Instrumentation7
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging7
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity7
Radiation Dosimetry, Artificial Intelligence and Digital Twins: Old Dog, New Tricks7
Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America7
Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration7
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma7
PET/CT Limitations and Pitfalls in Urogenital Cancers7
Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies7
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma7
Current Status of SPECT Radiopharmaceuticals for Specific Bacteria Imaging7
A role of FDG PET/CT for Response Assessment in Large Vessel Disease?7
Imaging of Spondylodiscitis: An Update7
New Approaches for Imaging Bacteria7
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients7
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers7
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-196
FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma6
Imaging of Cardiac Transplantation: An Overview6
Radiotheranostics Global Market and Future Developments6
Radiation Dose to Pediatric Patients From Radiopharmaceuticals6
Molecular Imaging in Inflammatory Bowel Disease6
Radiomicrosphere Dosimetry: Principles and Current State of the Art6
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update6
Molecular Imaging of Pituitary Tumors6
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case6
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma6
Safe Pulmonary Scintigraphy in the Era of COVID-196
The Impact of COVID-19 on Nuclear Medicine in Europe5
Imaging of Gastrointestinal Bleeding: An Update5
FDG PET/CT for Staging and Restaging Malignant Mesothelioma5
State of the Art Imaging of Osteoporosis5
Imaging in Renal Transplants: An Update5
PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview5
Functional Imaging in Musculoskeletal Disorders in Menopause5
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review5
Present status and future trends in molecular imaging of lymphocytes5
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices5
Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals5
Hybrid imaging of Diabetic Foot Infections5
A Role of Non-FDG Tracers in Lung Cancer?5
Prognostic Value of PSMA PET/CT in Prostate Cancer5
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases5
How to Report PSMA PET5
18F-FDG PET/CT for Response Assessment in Lung Cancer5
Preclinical Evaluation of Novel PET Probes for Dementia5
Advances in PET Imaging of the CXCR4 Receptor: [68Ga]Ga-PentixaFor5
Advanced Imaging for Detection of Foci of Infection in Staphylococcus aureus Bacteremia- Can a Scan Save Lives?5
0.023776054382324